METHOD FOR DIFFERENTIATING MESENCHYMAL STEM CELL INTO NEURAL CELL AND PHARMACEUTICAL COMPOSITION CONTAINING THE NEURAL CELL FOR NEURODEGENERATIVE DISEASE

Patent №

US 7,635,591

Granted

2009-12-22

Filed 2006

Owner

FCB PHARMICELL CO., LTD.

+3 more

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

10595620

The present invention provides a method of differentiating and proliferating a mesenchymal stem cell into the neural cell by culturing in a medium comprising an epidermal growth factor and a hepatocyte growth factor after confluent culture of the mesenchymal stem cell. The present invention provides more effective method of differentiating and proliferating the mesenchymal stem cell or the mononuclear cell comprising the mesenchymal stem cell into the neural cell with a neuron and an astrocyte in terms of time, efficiency and maturity as compared with conventional methods.

AI hardwareC12N 5/0618A61P 9/10A61P 17/02A61P 21/04A61P 25/00A61P 25/14A61P 25/16A61P 25/28+4 more

AI classification

AI hardware0.87
Machine learning0.01
Natural language0.00
Vision0.00
Speech0.00
Knowledge representation0.00
Planning0.00
Evolutionary computation0.00

Ownership

FCB PHARMICELL CO., LTD.

assignment · 175590733

HYUN-SOO KIM

assignment · 175590733

PHARMICELL CO., LTD.

namechg · 276210702

KIM, HYUN-SOO

namechg · 276210702

Assignors

KIM, HYUN-SOO, KANG, YOUNG-MO, LEE, KYUNG-BOCK, PARK, SANG-KYO, LEE, SANG-KAP

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC